CYCLOPHOSPHAMIDE FOR , USP for Mantle cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 21 adverse event reports in the FDA FAERS database where CYCLOPHOSPHAMIDE FOR , USP was used for Mantle cell lymphoma.
Most Reported Side Effects for CYCLOPHOSPHAMIDE FOR , USP
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 73 | 20.1% | 73 | 1 |
| Neoplasm progression | 62 | 17.1% | 62 | 0 |
| Disease progression | 39 | 10.7% | 6 | 0 |
| Neutropenia | 32 | 8.8% | 21 | 0 |
| Thrombocytopenia | 23 | 6.3% | 22 | 0 |
| Exposure during pregnancy | 21 | 5.8% | 0 | 0 |
| Acute graft versus host disease | 20 | 5.5% | 0 | 0 |
| Leukaemia recurrent | 18 | 5.0% | 18 | 0 |
| Disease recurrence | 16 | 4.4% | 13 | 0 |
| No adverse event | 15 | 4.1% | 0 | 0 |
| Liver function test abnormal | 7 | 1.9% | 0 | 0 |
| Precursor t-lymphoblastic lymphoma/leukaemia recurrent | 6 | 1.7% | 0 | 0 |
| Bacteraemia | 5 | 1.4% | 0 | 0 |
| Chronic graft versus host disease | 5 | 1.4% | 0 | 0 |
| Dehydration | 5 | 1.4% | 0 | 4 |
Other Indications for CYCLOPHOSPHAMIDE FOR , USP
Breast cancer (98)
Acute leukaemia (25)
Prophylaxis against graft versus host disease (25)
Blast crisis in myelogenous leukaemia (21)
Leukaemia (18)
B-cell lymphoma (15)
Plasma cell myeloma (14)
Acute lymphocytic leukaemia (12)
Diffuse large b-cell lymphoma (12)
Myelodysplastic syndrome (12)
Other Drugs Used for Mantle cell lymphoma
IBRUTINIB (6,306)
RITUXIMAB (3,940)
LENALIDOMIDE (2,989)
CYCLOPHOSPHAMIDE (1,815)
DOXORUBICIN (1,396)
VENETOCLAX (1,367)
VINCRISTINE (1,361)
BENDAMUSTINE (1,227)
CYTARABINE (1,174)
DEXAMETHASONE (949)